Current issue
Volume 22(2); September 2022
-
Combination of interventional oncology local therapies and immunotherapy for the treatment of hepatocellular carcinoma
Dong-Hyun Kim
J Liver Cancer. 2022;22(2):93-102.
Review ArticleApril 22, 2022
-
Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma
Eun-Ji Choi, Young-Joon Kim
J Liver Cancer. 2022;22(2):103-114.
Review ArticleSeptember 22, 2022
-
The dual role of transforming growth factor-beta signatures in human B viral multistep hepatocarcinogenesis: early and late responsive genes
Jeong Eun Yoo, Ji Hae Nahm, Young-Joo Kim, Youngsic Jeon, Young Nyun Park
J Liver Cancer. 2022;22(2):115-124.
Original ArticleMay 20, 2022
-
Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment
Young-Hwan Ahn, Heirim Lee, Ji Eun Han, Hyo Jung Cho, Jae Youn Cheong, et al.
J Liver Cancer. 2022;22(2):125-135.
Original ArticleJune 28, 2022
-
Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study
Jeong Yun Jang, Jinhong Jung, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, et al.
J Liver Cancer. 2022;22(2):136-145.
Original ArticleSeptember 16, 2022
-
Indications for open hepatectomy in the era of laparoscopic liver resection: a high volume single institutional study
Sung Jun Jo, Jinsoo Rhu, Jong Man Kim, Gyu-Seong Choi, Jae-Won Joh
J Liver Cancer. 2022;22(2):146-157.
Original ArticleSeptember 14, 2022
-
Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology
Wonjoon Jang, Hye Won Lee, Jae Seung Lee, Beom Kyung Kim, Seung Up Kim, et al.
J Liver Cancer. 2022;22(2):158-166.
Original ArticleSeptember 27, 2022
-
The diagnostic value of circulating tumor DNA in hepatitis B virus induced hepatocellular carcinoma: a systematic review and meta-analysis
Young Chang, Soung Won Jeong, Jae Young Jang, Hyuksoo Eun, Young‑Sun Lee, et al.
J Liver Cancer. 2022;22(2):167-177.
Original ArticleSeptember 29, 2022
-
Is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis C virus-related hepatocellular carcinoma?
Hye Won Lee
J Liver Cancer. 2022;22(2):91-92.
EditorialSeptember 29, 2022
-
Fibrolamellar hepatocellular carcinoma that was successfully treated with surgical resection: a case report
Seong Kyun Na
J Liver Cancer. 2022;22(2):178-182.
Case ReportJune 22, 2022
-
Combination of interventional oncology local therapies and immunotherapy for the treatment of hepatocellular carcinoma
Dong-Hyun Kim
J Liver Cancer. 2022;22(2):93-102.
Review ArticleApr 22, 2022
-
Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma
Eun-Ji Choi, Young-Joon Kim
J Liver Cancer. 2022;22(2):103-114.
Review ArticleSep 22, 2022
-
The dual role of transforming growth factor-beta signatures in human B viral multistep hepatocarcinogenesis: early and late responsive genes
Jeong Eun Yoo, Ji Hae Nahm, Young-Joo Kim, et al.
J Liver Cancer. 2022;22(2):115-124.
Original ArticleMay 20, 2022
-
Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment
Young-Hwan Ahn, Heirim Lee, Ji Eun Han, et al.
J Liver Cancer. 2022;22(2):125-135.
Original ArticleJun 28, 2022
-
Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study
Jeong Yun Jang, Jinhong Jung, Danbi Lee, et al.
J Liver Cancer. 2022;22(2):136-145.
Original ArticleSep 16, 2022
-
Indications for open hepatectomy in the era of laparoscopic liver resection: a high volume single institutional study
Sung Jun Jo, Jinsoo Rhu, Jong Man Kim, et al.
J Liver Cancer. 2022;22(2):146-157.
Original ArticleSep 14, 2022
Recent Issues
-
Vol.22, No.2,
September 2022
-
Vol.22, No.1,
March 2022
-
Vol.21, No.2,
September 2021
-
Vol.21, No.1,
March 2021
-
Vol.20, No.2,
September 2020
-
Vol.20, No.1,
March 2020
-
Vol.19, No.2,
September 2019
-
Vol.19, No.1,
March 2019
E-submission
THE KOREAN LIVER CANCER ASSOCIATION
Follow JLC on Twitter